BlackRock’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-127,723
| Closed | -$50.8K | – | 5562 |
|
|
2023
Q3 | $50.8K | Sell |
127,723
-2,153
| -2% | -$1.06K | ﹤0.01% | 4999 |
|
|
2023
Q2 | $89.6K | Buy |
129,876
+33,527
| +35% | +$216K | ﹤0.01% | 4947 |
|
|
2023
Q1 | $760K | Sell |
96,349
-4,276
| -4% | -$14.9K | ﹤0.01% | 4416 |
|
|
2022
Q4 | $90.6K | Hold |
100,625
| – | – | ﹤0.01% | 5071 |
|
|
2022
Q3 | $110K | Hold |
100,625
| – | – | ﹤0.01% | 5152 |
|
|
2022
Q2 | $124K | Sell |
100,625
-20,064
| -17% | -$26.8K | ﹤0.01% | 5175 |
|
|
2022
Q1 | $285K | Sell |
120,689
-981
| -0.8% | -$2.33K | ﹤0.01% | 5026 |
|
|
2021
Q4 | $378K | Buy |
121,670
+1,050
| +0.9% | +$3.49K | ﹤0.01% | 4955 |
|
|
2021
Q3 | $490K | Buy |
120,620
+4,138
| +4% | +$17.2K | ﹤0.01% | 4757 |
|
|
2021
Q2 | $564K | Sell |
116,482
-205,300
| -64% | -$921K | ﹤0.01% | 4665 |
|
|
2021
Q1 | $1.67M | Buy |
321,782
+7,165
| +2% | +$49.9K | ﹤0.01% | 4346 |
|
|
2020
Q4 | $2.1M | Buy |
314,617
+28,160
| +10% | +$231K | ﹤0.01% | 4028 |
|
|
2020
Q3 | $2.92M | Buy |
286,457
+1,006
| +0.4% | +$11.8K | ﹤0.01% | 3792 |
|
|
2020
Q2 | $3.58M | Buy |
+285,451
| New | +$3.99M | ﹤0.01% | 3650 |
|
|
2019
Q3 | – | Sell |
-1,158
| Closed | -$11K | – | 5130 |
|
|
2019
Q2 | $11K | Sell |
1,158
-2,932
| -72% | -$28.1K | ﹤0.01% | 4764 |
|
|
2019
Q1 | $40K | Sell |
4,090
-281
| -6% | -$3.1K | ﹤0.01% | 4508 |
|
|
2018
Q4 | $52K | Sell |
4,371
-80
| -2% | -$1.16K | ﹤0.01% | 4470 |
|
|
2018
Q3 | $72K | Buy |
4,451
+181
| +4% | +$4.3K | ﹤0.01% | 4504 |
|
|
2018
Q2 | $155K | Sell |
4,270
-893
| -17% | -$30.9K | ﹤0.01% | 4373 |
|
|
2018
Q1 | $161K | Buy |
5,163
+795
| +18% | +$25.3K | ﹤0.01% | 4253 |
|
|
2017
Q4 | $169K | Buy |
4,368
+299
| +7% | +$7.84K | ﹤0.01% | 4245 |
|
|
2017
Q3 | $87K | Buy |
4,069
+890
| +28% | +$16.5K | ﹤0.01% | 4387 |
|
|
2017
Q2 | $63K | Buy |
+3,179
| New | +$65.8K | ﹤0.01% | 4485 |
|
Other funds holding BLPH
BlackRock's BLPH Position: Q4 2023 in Review
BlackRock sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 127,723 shares — an estimated $50.8K sold.
BlackRock first reported a position in BLPH in Q2 2017 and held it in 23 quarters. The position peaked at $3.58M in Q2 2020. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.
- BlackRock reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
- BlackRock sold 127,723 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $50.8K.
- BlackRock first reported a position in Bellerophon Therapeutics, Inc. in Q2 2017 and held it in 23 quarters.
- BlackRock's Bellerophon Therapeutics, Inc. position peaked at $3.58M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.
Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.